Literature DB >> 9525574

Mtv-1 superantigen trafficks independently of major histocompatibility complex class II directly to the B-cell surface by the exocytic pathway.

M E Grigg1, C W McMahon, S Morkowski, A Y Rudensky, A M Pullen.   

Abstract

Presentation of the Mtv-1 superantigen (vSag1) to specific Vbeta-bearing T cells requires association with major histocompatibility complex class II molecules. The intracellular route by which vSag1 trafficks to the cell surface and the site of vSag1-class II complex assembly in antigen-presenting B lymphocytes have not been determined. Here, we show that vSag1 trafficks independently of class II to the plasma membrane by the exocytic secretory pathway. At the surface of B cells, vSag1 associates primarily with mature peptide-bound class II alphabeta dimers, which are stable in sodium dodecyl sulfate. vSag1 is unstable on the cell surface in the absence of class II, and reagents that alter the surface expression of vSag1 and the conformation of class II molecules affect vSag1 stimulation of superantigen reactive T cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525574      PMCID: PMC109690          DOI: 10.1128/JVI.72.4.2577-2588.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

1.  Isolation and characterization of the intracellular MHC class II compartment.

Authors:  A Tulp; D Verwoerd; B Dobberstein; H L Ploegh; J Pieters
Journal:  Nature       Date:  1994-05-12       Impact factor: 49.962

2.  Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes.

Authors:  S Amigorena; J R Drake; P Webster; I Mellman
Journal:  Nature       Date:  1994-05-12       Impact factor: 49.962

3.  Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells.

Authors:  M A West; J M Lucocq; C Watts
Journal:  Nature       Date:  1994-05-12       Impact factor: 49.962

4.  Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization.

Authors:  P A Roche; C L Teletski; E Stang; O Bakke; E O Long
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

5.  Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission.

Authors:  W Held; G A Waanders; A N Shakhov; L Scarpellino; H Acha-Orbea; H R MacDonald
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

6.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.

Authors:  L J Stern; J H Brown; T S Jardetzky; J C Gorga; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

7.  Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.

Authors:  Q Li; M K Spriggs; S Kovats; S M Turk; M R Comeau; B Nepom; L M Hutt-Fletcher
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Separation of subcellular compartments containing distinct functional forms of MHC class II.

Authors:  Y Qiu; X Xu; A Wandinger-Ness; D P Dalke; S K Pierce
Journal:  J Cell Biol       Date:  1994-05       Impact factor: 10.539

9.  Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen?

Authors:  R A Tripp; A M Hamilton-Easton; R D Cardin; P Nguyen; F G Behm; D L Woodland; P C Doherty; M A Blackman
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

10.  B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens.

Authors:  U Beutner; E Kraus; D Kitamura; K Rajewsky; B T Huber
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  4 in total

1.  Alternative proteolytic processing of mouse mammary tumor virus superantigens.

Authors:  F Denis; N H Shoukry; M Delcourt; J Thibodeau; N Labrecque; H McGrath; J S Munzer; N G Seidah; R P Sékaly
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Intercellular transfer of a soluble viral superantigen.

Authors:  M Reilly; D Mix; A A Reilly; X Y Ye; G M Winslow
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment.

Authors:  Mathieu Dubé; Bibhuti Bhusan Roy; Pierre Guiot-Guillain; Julie Binette; Johanne Mercier; Antoine Chiasson; Eric A Cohen
Journal:  PLoS Pathog       Date:  2010-04-08       Impact factor: 6.823

4.  BALB/Mtv-null mice responding to strong mouse mammary tumor virus superantigens restrict mammary tumorigenesis.

Authors:  Sanchita Bhadra; Mary M Lozano; Jaquelin P Dudley
Journal:  J Virol       Date:  2008-10-15       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.